American Association for Thoracic Surgery (AATS) American Association for Thoracic Surgery (AATS)
 
Home | About Us | Contact Us
 
Data from the STS General Thoracic Database: The Surgical Management of Primary Lung Tumors

Daniel Boffa2, Joshua D. Grab5, Mark S. Allen1, Henning A. Gaissert4, David H. Harpole3, Cameron D. Wright4; 1Mayo Clinic, Rochester, MN; 2Cleveland Clinic, Cleveland, OH; 3Duke University Medical Center, Durham, NC; 4Massachusetts General Hospital, Boston, MA; 5Duke Clinical Research Institute, Durham, NC


Objective: We wish to investigate the surgical management of primary lung tumors by board-certified thoracic surgeons that participate in the STS general thoracic database.

Methods: We identified all pulmonary resections registered in the STS General Thoracic Database (GTDB) categorized as primary lung tumor from 1999 to 2005. Among 25,801 procedures, a diagnosis of a primary lung tumor was found in 7,380 patients of whom 4,384 underwent pulmonary resections.

Results: There were 2,166 men and 2,218 women with a median age of 68 years (range 6 to 104). Comorbidity was present in 2,990 patients (68%) and included hypertension in 49%, body mass index = 30 in 26%, coronary artery disease in 20%, and diabetes mellitus in 12%. A history of smoking was present in 84% of patients. Pulmonary function data (available in 81% of patients) showed a median predicted FEV1 of 78% and median predicted DLCO of 71%. Mediastinoscopy was performed at the time of resection in 659 patients (15%). The surgical approach consisted of lateral thoracotomy in 3,351 patients (76%), video assisted thoracic surgery in 974 (22%), and others in 59 (1.3%). The type of resection was single wedge resection in 602 (13.7%), multiple wedge resections in 197 (4.5%), segmentectomy in 234 (5.3%), lobectomy in 2,909 (66%), bilobectomy in 175 (4.0%), and pneumonectomy in 267 (6.1%). Mediastinal lymph node dissection was performed in 1,809 (41%), nodal sampling in 327 (7.5%) and nodal biopsy in 231 (5.3%). Pathological stage was stated in 2,599 (59.3%) procedures and was stage 0 in 8 (0.31%), IA in 1,110 (43%), IB in 684 (26%), IIA in 101 (3.9%), IIB in 230 (8.8%), IIIA in 240 (9.2%), IIIB in 104 (4.0%) and IV in 122 (4.7%). Operative mortality was 2.0 % (86 patients). One or more postoperative events occurred in 38%: atrial arrythmia in 472 (10.8%), air leak in 361 (8.2%), blood transfusion in 162 (3.7%), pneumonia in 147 (3.4%), reintubation in 145 (3.3%) or atelectasis in 143 (3.3%). Median length of stay was 5 days (range 0 to 277).

Conclusion: The STS GTDB provides information about the current surgical management of lung cancer. A similar number of men and women underwent resection and comorbidities were frequent. Thoracotomy remains the preferred operative approach. Operative mortality is low, while postoperative events are common.


Back to Annual Meeting
Back to Program Outline

 
   Home | About Us | Contact Us | Policies
Copyright© American Association for Thoracic Surgery.
All rights reserved. IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.